Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAD | P27708 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.38 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.38 |
| ▸ | ITGAV | P06756 | 1/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.38 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.38 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.38 |
| ▸ | ITGAL | P20701 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydroorotate SCHEMBL29901858 | 1.00 | CAD (0.43) | CADGAAMAPTHTTEGLN1 | |
| Dihydroorotate SCHEMBL121953 | 1.00 | CAD (0.43) | CADGAAMAPTHTTEGLN1 | |
| Dihydroorotate SCHEMBL758070 | 1.00 | CAD (0.43) | CADGAAMAPTHTTEGLN1 | |
| Dihydroorotate SCHEMBL20818976 | 0.85 | MAPT (0.38) | CADGAAMAPTHTTALDH1A1 | |
| SCHEMBL690090 | 0.84 | — | — | |
| SCHEMBL690089 | 0.84 | — | — | |
| SCHEMBL1300246 | 0.84 | — | — | |
| SCHEMBL16467758 | 0.81 | CAD (0.48) | CADGAAMAPTHTTEGLN1 | |
| SCHEMBL6950284 | 0.81 | — | — | |
| SCHEMBL23182639 | 0.81 | CRBN (0.38) | CADHTTITGB3ITGB2ITGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4537111-A2 | MULTI-OMICS ASSESSMENT | Prognomiq Inc (US) | 2025-04-16 | — | — | EP | claimed |
| CN-117265603-A | Galvanized brightening agent composition for ship corrosion prevention and preparation method thereof | 姚春雷 | 2023-12-22 | — | — | CN | claimed |
| WO-2023240046-A2 | MULTI-OMICS ASSESSMENT | PrognomIQ, Inc. (US) | 2023-12-14 | — | — | WO | claimed |
| US-20230346831-A1 | METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE | CORNELL UNIVERSITY (US) | 2023-11-02 | — | — | US | claimed |
| WO-2023144235-A1 | METHODS FOR MONITORING AND TREATING WARBURG EFFECT IN PATIENTS WITH PI3K-RELATED DISORDERS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-08-03 | — | — | WO | claimed |
| CN-111289638-A | Application of serum metabolism marker in preparation of diabetic nephropathy early diagnosis reagent and kit | 浙江大学 | 2020-06-16 | — | — | CN | claimed |
| CN-103992392-A | Solid-phase synthesis method of degarelix | TAIZHOU SHIMEIKANG POLYPEPTIDE DRUG TECHNOLOGY CO LTD | 2014-08-20 | — | — | CN | claimed |
| CN-102864196-B | Method for preparing alpha-aspartyl small peptide by dihydroorotic acid enzyme method | NANJING UNIVERSITY OF TECHNOLOGY | 2014-07-02 | — | — | CN | claimed |
| US-8494779-B2 | Method for screening essential metabolites in growth of microorganisms | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2013-07-23 | — | — | US | claimed |
| US-20100143911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2010-06-10 | — | — | US | claimed |
| EP-2097743-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | Korea Advanced Institute of Science and Technology (KR) | 2009-09-09 | — | — | EP | claimed |
| US-20080248493-A1 | ACRIDINIUM PHENYL ESTERS USEFUL IN THE ANALYSIS OF BIOLOGICAL SAMPLES | ABBOTT LABORATORIES | 2008-10-09 | — | — | US | claimed |
| WO-2008078911-A1 | METHOD FOR SCREENING ESSENTIAL METABOLITES IN GROWTH OF MICROORGANISMS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-07-03 | — | — | WO | claimed |
| WO-2005100382-A1 | VERTEBRATE PEPTIDE MODULATORS OF LIPID METABOLISM | BLM GROUP, INC. (US) | 2005-10-27 | — | — | WO | claimed |
| US-20050222040-A1 | Vertebrate peptide modulators of lipid metabolism | BLM GROUP, INC. (US) | 2005-10-06 | — | — | US | claimed |
| EP-0673783-B1 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORP (US) | 2000-07-05 | — | — | EP | claimed |
| EP-4729603-A2 | METABOLOMIC CHARACTERIZATION OF MICROORGANISMS | Lewis, Ian Andrew (CA) | 2026-04-22 | — | — | EP | disclosed |
| US-20260097019-A1 | METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS | AURIGENE ONCOLOGY LTD (IN) | 2026-04-09 | — | — | US | disclosed |
| EP-0673783-A2 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | disclosed |
| EP-0338499-A2 | Stabilized highly unsaturated fatty acids and derivatives of such acids | NABISCO BRANDS, INC. (US) | 1989-10-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097019-A1 | METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS | MALT1, BRDT, BCL6 | CAD 4656/4885GAA 2639/4885MAPT 2427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.